Inhibition of Fibrinolysis by Coagulation Factor XIII
The inhibitory effect of coagulation factor XIII (FXIII) on fibrinolysis has been studied for at least 50 years. Our insight into the underlying mechanisms has improved considerably, aided in particular by the discovery that activated FXIII cross-links α2-antiplasmin (α2AP) to fibrin. In this review...
Main Authors: | Dingeman C. Rijken, Shirley Uitte de Willige |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2017/1209676 |
Similar Items
-
Clot Structure and Fibrinolysis in Thrombosis and Hemostasis
by: Zsuzsa Bagoly, et al.
Published: (2017-01-01) -
Studies of Coagulation and Fibrinolysis
by: Kim, Paul Ye Sir
Published: (2009) -
Aberrant Factors of Fibrinolysis and Coagulation in Pancreatic Cancer
by: Fang L, et al.
Published: (2021-01-01) -
Coagulation and Fibrinolysis in Obstructive Sleep Apnoea
by: Andras Bikov, et al.
Published: (2021-03-01) -
Coagulation and Fibrinolysis in Kidney Graft Rejection
by: Giovanni Stallone, et al.
Published: (2020-08-01)